We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

151 hedge funds and large institutions have $396M invested in Sciclone Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $210K | Put options by funds: $136K

35% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 46

0% more funds holding

Funds holding: 151 → 151 (0)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

24% less capital invested

Capital invested by funds: $521M → $396M (-$124M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
151
Holders Change
–
Holders Change %
0%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
22
Increased
62
Reduced
46
Closed
22
Calls
$210K
Puts
$136K
Net Calls
+$74K
Net Calls Change
-$1.21M

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$22.7M
2
BFA
BlackRock Fund Advisors
California
+$3.86M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$3.46M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.93M
5
American Century Companies
American Century Companies
Missouri
+$2.48M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$35.4M
2
SCM
Stonepine Capital Management
Oregon
-$14.1M
3
LSV Asset Management
LSV Asset Management
Illinois
-$8.04M
4
Invesco
Invesco
Georgia
-$5.87M
5
SI
Sensato Investors
California
-$3.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$3.31M +$283K +25,953 +9%
AllianceBernstein
27
AllianceBernstein
Tennessee
$3.26M +$1.72M +158,070 +99%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$3.14M -$1.67M -153,326 -33%
GT
29
Glenmede Trust
Pennsylvania
$3.13M – – –
PAM
30
Panagora Asset Management
Massachusetts
$2.93M +$1.47M +135,322 +90%
Ameriprise
31
Ameriprise
Minnesota
$2.53M +$79K +7,250 +3%
SAMC
32
Shinko Asset Management Company
Japan
$2.28M -$1.11M -101,824 -31%
Fisher Asset Management
33
Fisher Asset Management
Washington
$2.28M -$819K -75,187 -25%
BIM
34
BlackRock Investment Management
Delaware
$2.24M -$4.07K -374 -0.2%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$2.15M +$365K +33,500 +19%
Millennium Management
36
Millennium Management
New York
$2.13M +$2.27M +208,255 New
GCP
37
GSA Capital Partners
United Kingdom
$2.07M -$82.8K -7,600 -4%
MC
38
Menta Capital
California
$2.05M +$571K +52,398 +35%
CAM
39
ClariVest Asset Management
California
$2M +$388K +35,617 +22%
Two Sigma Investments
40
Two Sigma Investments
New York
$2M +$1.27M +116,755 +149%
MCM
41
Matarin Capital Management
New York
$1.79M +$284K +26,078 +18%
Marshall Wace
42
Marshall Wace
United Kingdom
$1.74M +$1.85M +169,437 New
SFM
43
Systematic Financial Management
New Jersey
$1.64M +$215K +19,750 +14%
Prudential Financial
44
Prudential Financial
New Jersey
$1.55M -$374K -34,380 -19%
Skandinaviska Enskilda Banken (SEB)
45
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.39M -$1.42M -130,400 -49%
JIM
46
Jupiter Investment Management
United Kingdom
$1.35M +$1.44M +132,215 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$1.32M -$64.3K -5,900 -4%
TC
48
TFS Capital
Pennsylvania
$1.28M +$910K +83,572 +204%
Deutsche Bank
49
Deutsche Bank
Germany
$1.27M +$202K +18,580 +18%
ACM
50
Ativo Capital Management
Illinois
$1.21M +$220K +20,222 +21%
1
2
3 4 5

SCLN Hedge Fund Activity: Q3 2016 in Review

151 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2016, worth a combined $396M — down 24% from $521M a quarter earlier.

Fund positioning in SCLN was balanced in Q3 2016: 22 funds opened new positions, 22 closed out, 62 added to existing stakes and 46 trimmed.

The largest buyer was Numeric Investors, adding an estimated $22.7M. The largest seller was Franklin Resources, cutting an estimated $35.4M.

  • 151 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $396M of Sciclone Pharmaceuticals Inc stock for Q3 2016, down 24% quarter-over-quarter.
  • 22 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2016 and 22 closed out, a net change of 0 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q3 2016 was Numeric Investors, an estimated $22.7M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q3 2016 was Franklin Resources, an estimated $35.4M sold.

Based on aggregated 13F filings for Q3 2016.